Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle-Reference-Cited by-同舟云学术

Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle

Published:2020-01 Issue:4 Volume:38 Page:769-778
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Steigerwald Robin,Brake David A.,Barrera José,Schutta Christopher J.,Kalla Markus,Wennier Sonia T.,Volkmann Ariane,Hurtle William,Clark Benjamin A.,Zurita Mariceny,Pisano Melia,Kamicker Barbara J.^ORCID,Puckette Michael C.^ORCID,Rasmussen Max V.,Neilan John G.^ORCID

Funder

U.S. Department of Homeland Security Science and Technology

Bavarian Nordic

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference49 articles.

1. OIE. World Organisation for Animal Health. Foot and Mouth Disease 2013 [accessed 01 July 2019]. Available from: http://www.oie.int/fileadmin/Home/eng/Animal_Health_in_the_World/docs/pdf/Disease_cards/FOOT_AND_MOUTH_DISEASE.pdf.

2. Research on foot-and-mouth disease. III. The cultivation of the virus on a practical scale in explantations of bovine tongue epithelium;Frenkel;Am J Vet Res,1951

3. The need for improved vaccines against foot-and-mouth disease;de Los;Curr Opin Virol,2018

4. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine;Barrera;Vaccine,2018

5. Use of ENABL(R) adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine;Barrera;Vaccine,2018